ERBB2 and cancer: The novel stimulatory mechanism of ErbB2 for its homodimerization and activation by cis-interacting with nectin-4, which mainly leads to the selective activation of the PI3K-AKT signalling pathway, may be involved in the enhanced DNA synthesis of cancer cells in which nectin-4 is upregulated.